COMMUNIQUÉS West-GlobeNewswire

Synthorx Initiates Patient Dosing in Australia and Announces Clearance of IND in the U.S. for Lead Immuno-oncology Product Candidate, THOR-707
24/07/2019
SAN DIEGO, July 24, 2019 (GLOBE NEWSWIRE) -- Synthorx, Inc. (NASDAQ: THOR), a clinical-stage biotechnology company developing optimized therapeutics for cancer and autoimmune disorders, announced today it has opened [...]
Chembio Diagnostics to Report Second Quarter 2019 Financial Results on August 6, 2019
24/07/2019
MEDFORD, N.Y., July 24, 2019 (GLOBE NEWSWIRE) -- Chembio Diagnostics, Inc. (Nasdaq: CEMI), a leading point-of-care diagnostics company focused on infectious diseases, announced today that it will release financial [...]
Rhythm Pharmaceuticals Announces Appointment of Stuart Arbuckle to its Board of Directors
24/07/2019
BOSTON, July 24, 2019 (GLOBE NEWSWIRE) -- Rhythm Pharmaceuticals, Inc. (Nasdaq:RYTM), a biopharmaceutical company focused on the development and commercialization of therapeutics for the treatment of rare genetic [...]
NeuBase Therapeutics Appoints Danith Ly, Ph.D. as Chief Scientific Officer
24/07/2019
Dr. Ly is a leader in the field of peptide nucleic acids and the primary inventor of NeuBase’s proprietary PATrOL™ platform PITTSBURGH, July 24, 2019 (GLOBE NEWSWIRE) -- NeuBase Therapeutics, Inc. (Nasdaq: NBSE) (“ [...]
Cannabis Suisse Corp. is Happy to Announce the Launching of a New Product in Our Retail Brand Alpine Cannabis
24/07/2019
ALPINE CANNABIS CBD PURE BASE: BOOST YOUR E-LIQUIDS Dietikon, Switzerland, July 24, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Alpine Cannabis CBD Pure Base is an e-liquid for electronic cigarettes. It’s an amazing [...]
Julie Stephenson Joins BioSig as Senior Director of Clinical Affairs
24/07/2019
Seasoned electrophysiology professional is the latest addition to the Company’s growing team Westport, CT, July 24, 2019 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (NASDAQ: BSGM), a medical device company [...]
Obalon Announces Second Quarter 2019 Financial Results
24/07/2019
SAN DIEGO, July 24, 2019 (GLOBE NEWSWIRE) -- Obalon Therapeutics, Inc. (NASDAQ:OBLN), a vertically integrated medical technology company with the first and only FDA-approved swallowable, gas-filled intragastric balloon [...]
Strongbridge Biopharma plc to Host Second Quarter 2019 Financial Results Conference Call on July 31, 2019
24/07/2019
DUBLIN, Ireland and TREVOSE, Pa., July 24, 2019 (GLOBE NEWSWIRE) -- Strongbridge Biopharma plc, (Nasdaq: SBBP), a global commercial-stage biopharmaceutical company focused on the development and commercialization of [...]
Microbot Medical Receives Notice of Allowance from the Israel Patent Office for a Patent Application covering a System for Reducing Dialysis Shunt Stenosis
24/07/2019
HINGHAM, Mass., July 24, 2019 (GLOBE NEWSWIRE) -- As it continues to expand and diversify its Intellectual Property (IP) portfolio, Microbot Medical (Nasdaq: MBOT) announced that it has received a Notice of Allowance [...]
T2 Biosystems Announces 2019 Second Quarter Financial and Operational Results Release and Conference Call Date
24/07/2019
LEXINGTON, Mass., July 24, 2019 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO), an emerging leader in the development of innovative medical diagnostic products for critical unmet needs in healthcare, announced [...]
Kura Oncology’s Menin-MLL Inhibitor KO-539 Receives Orphan Drug Designation from FDA for Treatment of Acute Myeloid Leukemia
24/07/2019
SAN DIEGO, July 24, 2019 (GLOBE NEWSWIRE) -- Kura Oncology, Inc. (Nasdaq: KURA), a clinical-stage biopharmaceutical company focused on the development of precision medicines for oncology, today announced that the U.S. [...]
Cytokinetics Announces Publication of Preclinical Data Demonstrating Fast Skeletal Muscle Troponin Activator Improves Muscle Energetics
24/07/2019
SOUTH SAN FRANCISCO, Calif., July 24, 2019 (GLOBE NEWSWIRE) -- Cytokinetics, Incorporated (Nasdaq: CYTK) today announced the publication of data in The Journal of Physiology demonstrating that a fast skeletal muscle [...]
ProMIS Neurosciences Announces Results of Annual Meeting of Shareholders
24/07/2019
ProMIS' shareholders show overwhelming support for all resolutions TORONTO and CAMBRIDGE, Mass., July 24, 2019 (GLOBE NEWSWIRE) -- ProMIS Neurosciences, Inc. (TSX: PMN) (OTCQB: ARFXF), a biotechnology company focused on [...]
CURE Pharmaceutical [OTCQB:CURR] Secures Patent on High Loading of Active Ingredient in Oral Thin Films
24/07/2019
OXNARD, Calif., July 24, 2019 (GLOBE NEWSWIRE) -- CURE Pharmaceutical (OTC:CURR), an innovative drug delivery and development company, today announced the allowance of U.S. Application No. 13/890,875. The new patent [...]
TherapyLine, le service de thérapie en ligne culturellement adapté aux musulmans, arrive aux États-Unis aujourd'hui
24/07/2019
DÉTROIT, 24 juill. 2019 (GLOBE NEWSWIRE) -- TherapyLine arrive sur le marché américain aujourd'hui pour proposer une thérapie professionnelle en ligne aux plus de 3,4 millions de musulmans qui vivent actuellement aux [...]
Trillium Therapeutics Provides Corporate Update
24/07/2019
FDA meeting scheduled to discuss the pivotal path for intratumoral TTI-621 in CTCL Intravenous TTI-621 protocol amended to enable dosing beyond 0.5 mg/kg and first patient cohort enrolling Enrollment in the first Simon’ [...]
EyePoint Pharmaceuticals Announces Second Quarter 2019 Financial Results Release Date and Conference Call Information
24/07/2019
WATERTOWN, Mass., July 24, 2019 (GLOBE NEWSWIRE) -- EyePoint Pharmaceuticals, Inc. (NASDAQ:EYPT), a specialty biopharmaceutical company committed to developing and commercializing innovative ophthalmic products, will [...]
TRU NIAGEN® Expands Canadian Retail Footprint with Distribution at Whole Foods Ontario Locations
24/07/2019
Tru Niagen (nicotinamide riboside) now available for purchase in 100+ retailers across Canada LOS ANGELES, July 24, 2019 (GLOBE NEWSWIRE) -- ChromaDex Corp. (NASDAQ:CDXC) announced today its flagship consumer product, [...]
Amarin to Report Second Quarter 2019 Results and Host Conference Call on July 31, 2019
24/07/2019
BEDMINSTER, N.J., and DUBLIN, Ireland, July 24, 2019 (GLOBE NEWSWIRE) -- Amarin Corporation plc (NASDAQ:AMRN), a pharmaceutical company focused on improving cardiovascular health, today announced that it will host a [...]

Pages